Back to Trades
Total Value
$2.7M
Net $2.7M sold
Filing Date
Jul 10, 2026
2 transactions
Sales
$2.7M
1 transaction
Trade Summary
On Jul 8, 2026 through Jul 10, 2026, HENDERSON MICHAEL THOMAS, Chief Executive Officer, Director, sold $2.7M of Apogee Therapeutics, Inc. (APGE) across 2 transactions. The filing covers Common Stock and reflects net selling of $2.7M. Reported prices ranged from $133.63. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Apogee Therapeutics, Inc.
- Ticker Symbol
- APGE
- CIK
- 0001974640
Insider Information
- Role
- Chief Executive Officer, Director
- Location
- SAN FRANCISCO, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001104659-26-082758
- Form Type
- 4
- Net Trading Amount
- -$2.7M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 20,000 | $133.63 | Sale | $2.7M |
| Jul 10, 2026 | Common Stock | 75,046 | — | Bona Fide Gift | — |
Want live alerts when HENDERSON MICHAEL THOMAS trades again?
Download Insider Trades to track APGE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
- (F2)The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.52 to $133.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F3)This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.